Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin's lymphoma.
Frame DG, Geer M, Kasha S, Markstrom D, Scappaticci G, Feeney T, Hayduk A, Mansoor HM, Oberfeld A, D'Antonio H, Anand S, Choi SW, Maciejewski J, Pawarode A, Riwes MM, Tewari M, Magenau J, Ghosh M.
Frame DG, et al. Among authors: geer m.
Front Immunol. 2024 Jun 14;15:1403145. doi: 10.3389/fimmu.2024.1403145. eCollection 2024.
Front Immunol. 2024.
PMID: 38947326
Free PMC article.